Premium USA-Made Research Compounds
Browse lab-tested peptides, research liquids, capsules and more.
There’s a category of peptide research that’s been running for over forty years, produced hundreds of peer-reviewed papers, and has largely flown under the radar of Western geroscience — until recently. Khavinson bioregulators sit at the intersection of aging biology, epigenetics, and tissue-specific gene regulation. Short-chain peptides, usually two to four amino acids, with proposed mechanisms involving chromatin remodeling and transcriptional control. The science is old enough to have a real literature behind it. It’s also unusual enough that investigators approaching it for the first time benefit from some orientation.
This guide covers the framework, the key compounds — Epitalon, Pinealon, Prostamax — and several others that appear consistently in the geroscience literature. It also covers where the evidence is genuinely strong, where it’s weaker, and what the honest research questions look like in 2025–2026. For laboratory and preclinical research use only.
Table of Contents
Looking for Premium Research Compounds?
Who Is Vladimir Khavinson?
Vladimir Khavinson is the Director of the St. Petersburg Institute of Bioregulation and Gerontology, a position he’s held since the institute was founded in 1992 under the Russian Academy of Medical Sciences.
He’s not a fringe figure. Over 700 peer-reviewed publications. Full member of the Russian Academy of Sciences. The bioregulator research program he developed has been running continuously for more than four decades, producing a body of literature that spans cell culture, animal models, and longitudinal population studies. Western scientists have been skeptical of some of it — partly due to publication in Russian-language journals, partly due to the broad claims made — but the raw volume of experimental output has made engagement unavoidable for anyone working seriously in aging biology.
Whether that framing is ultimately correct at the mechanistic level is still an open question. What isn’t open is that the experimental results have been reproducible enough, in enough models, to warrant serious investigation.
Cytomaxes and Cytogens: The Two-Track Framework
Khavinson’s group developed two generations of compounds that appear interchangeably under the “bioregulator” umbrella:
Cytomaxes are the first generation — complex peptide fractions extracted from specific organs. Thymus extract, pineal gland extract, prostate extract, brain cortex extract. They’re not pure single peptides; they’re active fractions with multiple components, developed before the individual active sequences were characterized. Many of the older clinical research studies in Khavinson’s literature use cytomaxes rather than synthetic versions.
Cytogens (sometimes written cytogenes) are the second generation — synthetic short-chain peptides with defined sequences, developed once researchers isolated the active components from the cytomaxe fractions. These are the compounds that get discussed in modern research contexts: tetrapeptides, tripeptides, dipeptides with known amino acid sequences and reproducible synthesis. Epitalon is a cytogen. So are Pinealon, Vilon, and most others in the list below.
The distinction matters for reading the literature. Early papers use cytomaxes; later papers use cytogens. The mechanistic proposals are similar but the experimental materials are not directly comparable.
The Short-Chain Peptide Mechanism — Chromatin and Gene Expression
Most bioactive peptides work at cell surface receptors. That’s the familiar story: ligand binds receptor, second messenger cascade fires, gene expression changes indirectly. Khavinson’s bioregulators propose something more direct. Short enough to penetrate cell nuclei, these peptides are hypothesized to interact with chromatin — binding specific DNA sequences in promoter regions through steric and electrostatic complementarity, altering histone modification patterns, and changing the accessibility of regulatory regions to transcription factors.
The sequence specificity is the key claim. Not random binding — sequence-specific recognition, analogous to how certain transcription factors bind defined promoter motifs. Specific dipeptide and tripeptide motifs matching corresponding nucleotide sequences.
Is this fully proven? Not at the level molecular biologists typically demand. The epigenetic interaction model is supported by binding studies and cocrystallization data from Khavinson’s group, but independent replication using contemporary structural biology tools is limited. What’s supported more broadly is the downstream functional observation: these short peptides alter gene expression in ways consistent with the proposed mechanism, and the effects are sequence-specific. The full mechanistic picture remains an active research question.
What It Is
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide: Ala-Glu-Asp-Gly. Four amino acids. Molecular weight of approximately 390 daltons. It was derived from Epithalamin — the original pineal gland cytomaxe — and is now the most extensively studied of all Khavinson bioregulators. The reason for that attention is telomere biology.
The Telomere Research
The headline finding from Epitalon research is telomerase activation. Given that telomere shortening is one of the most well-characterized hallmarks of cellular aging (per the Lopez-Otin framework), a compound that reliably activates telomerase is immediately interesting to geroscience researchers.
The proposed mechanism involves Epitalon modulating expression of the TERT (telomerase reverse transcriptase) gene through the chromatin interaction pathway described above. The correlation is consistent. Whether the chromatin interaction model is the correct mechanistic explanation for it — or whether other pathways are involved — is still being worked out.
The effect sizes in these studies are notable — not marginal. But they come primarily from one research institute, and independent replications with modern aging biology endpoints have been limited. That’s a real gap in the evidence base, and one that makes confident mechanistic interpretation difficult for investigators outside the group. The findings are compelling enough to warrant investigation; they’re not established enough to be treated as settled.
Research Applications
- Telomerase activation and telomere elongation research in aged cell models
- Pineal gland biology and melatonin synthesis studies
- Long-term rodent model work on age-associated pathology incidence
What It Is
Pinealon is a synthetic tripeptide: Glu-Asp-Arg. Three amino acids, derived from the same pineal gland source material as Epitalon, but with a focus that’s clearly oriented toward the nervous system rather than telomere biology. The research literature on Pinealon is smaller than Epitalon’s but has grown meaningfully in the past decade.
The circadian angle is active too. The findings are preliminary but interesting, particularly for researchers working on the circadian biology of aging.
Research Applications
- Circadian rhythm regulation in aging contexts
- Neuroinflammation — cytokine profiles in neural environments
Prostamax: The Prostate-Specific Bioregulator
What It Is
It represents the tissue-specificity principle of the Khavinson framework applied to a single organ system.
Research Findings
The mechanism involving zinc binding is notable. Zinc is a critical cofactor in prostate tissue — involved in citrate metabolism, testosterone conversion, and multiple enzymatic functions. Prostamax’s zinc-binding properties may underlie some of its observed effects on prostate-specific gene expression in animal models.
These findings place Prostamax in the context of prostate aging biology research — an area with obvious translational relevance but where Prostamax specifically sits in early preclinical stages outside Khavinson’s own work.
Research Applications
Other Key Bioregulators in the Khavinson Framework
Vilon (Lys-Glu)
A dipeptide with thymus-derived origins. Among the most studied of the cytogen dipeptides.
Thymalin
The original thymus cytomaxe. Unlike the cytogens, Thymalin is a complex extract rather than a defined sequence. It has the longest clinical investigational history of any compound in the bioregulator literature — longitudinal studies from Khavinson’s group spanning decades — but the undefined composition complicates mechanistic interpretation.
Cortagen (Ala-Glu-Asp-Pro)
A tetrapeptide derived from brain cortex. Structural similarity to Epitalon — both are tetrapeptides — but distinct in sequence and tissue target.
Vesugen (Lys-Glu-Asp)
A tripeptide derived from vascular tissue.
Cardiogen (Ala-Glu-Asp-Lys)
Cardiac tissue-derived tetrapeptide.
Compound Overview Table
| Compound | Sequence | Source Tissue | Primary Research Focus | Evidence Level |
|---|---|---|---|---|
| Epitalon | Ala-Glu-Asp-Gly | Pineal gland | Strongest; largest published dataset | |
| Pinealon | Glu-Asp-Arg | Pineal gland | Moderate; growing literature | |
| Prostamax | Zinc-binding peptide | Prostate tissue | Prostate aging, androgen signaling, zinc biology | Limited; primarily Khavinson group |
| Vilon | Lys-Glu | Thymus | Moderate; thymus connection well-characterized | |
| Thymalin | Complex extract | Thymus | Extensive historical data; complex composition | |
| Cortagen | Ala-Glu-Asp-Pro | Brain cortex | Early; primarily animal models | |
| Vesugen | Lys-Glu-Asp | Vascular tissue | Endothelial function, vascular aging | Early; emerging research |
| Cardiogen | Ala-Glu-Asp-Lys | Cardiac tissue | Early; animal model data available |
The Epigenetic Mechanism: What’s Established and What Isn’t
That’s a meaningful mechanistic claim that goes well beyond what most peptide research proposes.
What’s established: Khavinson’s group has published binding studies showing short-chain peptides interact with double-stranded DNA in a sequence-selective manner. Cocrystallization data has been published. Computational modeling of peptide-DNA interaction geometries has been performed. The evidence for some form of direct chromatin interaction is real and isn’t based solely on functional observations.
What’s not fully established: The precise stoichiometry and affinity of these interactions in living cells. Whether the chromatin binding model fully explains the downstream gene expression changes, or whether other mechanisms (including indirect ones, via GPCR or nuclear receptor pathways) are also contributing. And critically: independent structural characterization using modern cryo-EM, X-ray crystallography, or ChIP-seq approaches has been limited. The mechanistic evidence is suggestive rather than definitive by the standards contemporary structural biology applies.
For investigators approaching this literature, that ambiguity is worth holding.
Limitations of the Current Evidence Base
Direct about the gaps: most of the published Khavinson bioregulator literature comes from one research institution. That concentration raises questions about replication independence that would be resolved if other groups engaged more systematically. A handful of independent groups have published work in this area — particularly on Epitalon and Thymalin — but the volume of independent replication remains lower than the evidence base’s age would suggest it should be.
There’s also a comparison problem: the cytomaxe studies (complex extracts) and cytogen studies (defined synthetic peptides) are often cited together as if they’re directly comparable. They’re not. Complex extracts contain multiple active components; results from cytomaxe studies don’t cleanly predict the behavior of the derived synthetic peptides, even when the active fraction was the basis for the synthetic design.
The existing long-term rodent studies are valuable, but they’re not the most recent (most were published in the 1990s–2000s) and haven’t been repeated with modern aging biology endpoints like biological age clocks, senescent cell burden, or organ-level omics profiling.
Why 2025–2026 Interest Is Accelerating
Several converging factors are driving renewed attention. The longevity research field has expanded dramatically — funding, institutional support, and new investigators — and is systematically revisiting older findings with modern tools. Epitalon’s telomerase findings, in particular, sit squarely at the intersection of current interest in the hallmarks of aging. The Horvath biological age clock literature, the senescence biology field, the NAD+/sirtuin research community — all of these have created investigators with both the motivation and the tools to engage with bioregulator research properly.
The short-chain peptide field more broadly is also maturing. BPC-157, TB-500, and related compounds have generated significant modern research programs, creating infrastructure and investigator expertise that transfers reasonably well to Khavinson compounds. Researchers already working in the peptide biology space are encountering bioregulators and finding the entry point lower than it once was.
All compounds described in this article are for laboratory and preclinical research use only. Not for human administration or veterinary use outside approved research protocols. Investigators should follow all applicable institutional and regulatory requirements when working with these compounds.
Frequently Asked Questions
What is Epitalon and what is the core research finding?
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from the pineal gland cytomaxe Epithalamin. For research use only.
How do cytomaxes differ from cytogens?
Cytomaxes are complex organ tissue extracts (the first generation of Khavinson compounds), while cytogens are defined synthetic short-chain peptides (the second generation, developed after active fractions were isolated and characterized). Most modern research uses cytogens because their defined composition allows reproducible synthesis and cleaner mechanistic interpretation. For research use only.
What is the proposed chromatin interaction mechanism?
Khavinson’s group proposes that short-chain peptides penetrate cell nuclei and bind specific DNA sequences in promoter regions through sequence-specific steric and electrostatic complementarity. This modulates histone modification states and alters transcription factor recruitment. Binding evidence exists from Khavinson’s published work; full mechanistic characterization by independent structural biology approaches remains limited. For research use only.
What are the main gaps in the Khavinson bioregulator evidence base?
Primary gaps include: limited independent replication from outside Khavinson’s institute; conflation of cytomaxe and cytogen results in citation; long-term lifespan studies not repeated with modern biological aging endpoints; and mechanistic characterization of the chromatin interaction model requiring independent structural validation. For research use only.
Continue Your Research
Explore our complete catalog of premium research compounds.
